Posted on March 6, 2018 by Sitemaster
A group of Italian researchers have apparently shown that a copper-64 dichloride-based radiotracing agent (64CuCl2) is better than currently-used 18FCl radiotracers in the detection of biochemically recurrent prostate cancer with PET/CT scans … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: copper-64, imaging, PET/CT, radiotracer, scan | 3 Comments »
Posted on March 12, 2017 by Sitemaster
There seem to be clinical trials of new PET radiotracers for the detection of prostate cancer all the time. In addition to the FDA-approved [11C]choline, Na18F, FDG, and fluciclovine PET scans, most of the new PET scans target the PSMA protein on prostate cancer cells. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: bombesin, PET/CT, radiotracer, RGD, scan | 4 Comments »